Search

everythinglearnresearchcommunity

for

Search:↓

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

High-dose finasteride may help treat glioblastoma but needs localized delivery for effectiveness.

The new nasal gel for schizophrenia improved drug absorption and brain effects in rats.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Guilu Erxian Glue may help reduce chemotherapy side effects like weight loss and heart stress.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Gp₄G promotes hair growth and improves skin health.

Glycyrrhizic acid and licorice extract can significantly reduce unwanted hair growth.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

Enzymatic synthesis improved the water solubility of the flavonoid baicalin, which may help treat hair loss conditions.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.